RAGE and TLRs: Relatives, friends or neighbours?

Molecular Immunology

Volumn 56, Issue 4, 2013, Pages 739-744

  Ibrahim, Zaridatul Aini ^a,b,c   Armour, Carol L ^a   Phipps, Simon ^d   Sukkar, Maria B ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

High mobility group box 1 (HMGB1); Lipopolysaccharide (LPS); Pattern recognition receptors (PRRs); Receptor for advanced glycation end products (RAGE); S100 proteins; Toll like receptors (TLRs)

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN A; CALGRANULIN B; HIGH MOBILITY GROUP B1 PROTEIN; LIGAND; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION; INNATE IMMUNITY; MOLECULE; NONHUMAN; PHYSICAL CHEMISTRY; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; BIOLOGICAL MODEL; IMMUNOLOGY; METABOLISM;

CALGRANULIN A; CALGRANULIN B; HMGB1 PROTEIN; HUMANS; IMMUNITY, INNATE; LIGANDS; LIPOPOLYSACCHARIDES; MODELS, IMMUNOLOGICAL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84882785076     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.07.008     Document Type: Review

References (55)

1. Altwegg L.A., Neidhart M., Hersberger M., Müller S., Eberli F.R., Corti R., Roffi M., Sütsch G., Gay S., von Eckardstein A., Wischnewsky M.B., Lüscher T.F., Maier W. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. European Heart Journal 2007, 28:941-948.
2. Beutler B. TLR4: central component of the sole mammalian LPS sensor. Current Opinion in Immunology 2000, 12:20-26.
3. Botos I., Segal David M., Davies David R. The structural biology of Toll-like receptors. Structure (London, England: 1993) 2011, 19:447-459.
4. Boyd J.H., Kan B., Roberts H., Wang Y., Walley K.R. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circulation Research 2008, 102:1239-1246.
5. Chang Z.L. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflammation Research 2010, 59:791-808.
6. Cheng N., He R., Tian J., Ye P.P., Ye R.D. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. The Journal of Immunology 2008, 181:22-26.
7. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. Journal of Biological Chemistry 1999, 274:10689-10692.
8. da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. Journal of Biological Chemistry 2001, 276:21129-21135.
9. Dattilo B.M., Fritz G., Leclerc E., Vander Kooi C.W., Heizmann C.W., Chazin W.J. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 2007, 46:6957-6970.
10. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-[beta] peptide transport across the blood-brain barrier and accumulation in brain. Nature Medicine 2003, 9:907-913.
11. Fritz G. RAGE: a single receptor fits multiple ligands. Trends in Biochemical Sciences 2011, 36:625-632.
12. Fritz G., Botelho H.M., Morozova-Roche L.A., Gomes C.M. Natural and amyloid self-assembly of S100 proteins: structural basis of functional diversity. FEBS Journal 2010, 277:4578-4590.
13. Fukata M., Chen A., Vamadevan A.S., Cohen J., Breglio K., Krishnareddy S., Hsu D., Xu R., Harpaz N., Dannenberg A.J., Subbaramaiah K., Cooper H.S., Itzkowitz S.H., Abreu M.T. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007, 133:1869-1881.
14. Gebhardt C., Németh J., Angel P., Hess J. S100A8 and S100A9 in inflammation and cancer. Biochemical Pharmacology 2006, 72:1622-1631.
15. Ghavami S., Rashedi I., Dattilo B.M., Eshraghi M., Chazin W.J., Hashemi M., Wesselborg S., Kerkhoff C., Los M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. Journal of Leukocyte Biology 2008, 83:1484-1492.
16. Hermani A., de Servi B., Medunjanin S., Tessier P.A., Mayer D. S100A8 and S100A9 activate MAP kinase and NF-κB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Experimental Cell Research 2006, 312:184-197.
17. Hiratsuka S. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nature Cell Biology 2008, 10:1349-1355.
18. Hirschfeld M., Ma Y., Weis J.H., Vogel S.N., Weis J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. The Journal of Immunology 2000, 165:618-622.
19. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., Morser J., Stern D., Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Journal of Biological Chemistry 1995, 270:25752-25761.
20. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the lps gene product. The Journal of Immunology 1999, 162:3749-3752.
21. Hreggvidsdottir H.S., Lundberg A.M., Aveberger A.C., Klevenvall L., Andersson U., Harris H.E. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Molecular Medicine 2012, 18:224-230.
22. Hreggvidsdottir H.S., Östberg T., Wähämaa H., Schierbeck H., Aveberger A.-C., Klevenvall L., Palmblad K., Ottosson L., Andersson U., Harris H.E. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. Journal of Leukocyte Biology 2009, 86:655-662.
23. Huttunen H.J., Fages C., Kuja-Panula J., Ridley A.J., Rauvala H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Research 2002, 62:4805-4811.
24. Ichikawa M., Williams R., Wang L., Vogl T., Srikrishna G. S100A8/A9 activate key genes and pathways in colon tumor progression. Molecular Cancer Research 2011, 9:133-148.
25. Ivanov S., Dragoi A.-M., Wang X., Dallacosta C., Louten J., Musco G., Sitia G., Yap G.S., Wan Y., Biron C.A., Bianchi M.E., Wang H., Chu W.-M. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007, 110:1970-1981.
26. Jiang Q., Akashi S., Miyake K., Petty H.R. Cutting edge: lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-κB. Journal of Immunology 2000, 165:3541-3544.
27. Jordana T., Evdokia P. High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues. Oncology letters 2012, 3:214-218.
28. Liu R., Mori S., Wake H., Zhang J., Liu K., Izushi Y., Takahashi H.K., Peng B., Nishibori M. Establishment of in vitro binding assay of high mobility group box-1 and S100A12 to receptor for advanced glycation endproducts: heparin's effect on binding. Acta Medica Okayama 2009, 63:203-211.
29. Netea M.G., van Deuren M., Kullberg B.J., Cavaillon J.-M., Van der Meer J.W.M. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors?. Trends in Immunology 2002, 23:135-139.
30. Park J.S., Svetkauskaite D., He Q., Kim J.-Y., Strassheim D., Ishizaka A., Abraham E. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. Journal of Biological Chemistry 2004, 279:7370-7377.
31. Poltorak A., He X., Smirnova I., Liu M.-Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science 1998, 282:2085-2088.
32. Qin Y.-H., Dai S.-M., Tang G.-S., Zhang J., Ren D., Wang Z.-W., Shen Q. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. The Journal of Immunology 2009, 183:6244-6250.
33. Robinson M.J., Tessier P., Poulsom R., Hogg N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. Journal of Biological Chemistry 2002, 277:3658-3665.
34. Sakaguchi M., Murata H., Yamamoto K.-i., Ono T., Sakaguchi Y., Motoyama A., Hibino T., Kataoka K., Huh N.-h. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS ONE 2011, 6:e23132.
35. Schelbergen R.F.P., Blom A.B., van den Bosch M.H.J., Slöetjes A., Abdollahi-Roodsaz S., Schreurs B.W., Mort J.S., Vogl T., Roth J., van den Berg W.B., van Lent P.L.E.M. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Arthritis and Rheumatism 2012, 64:1477-1487.
36. Srikrishna G., Panneerselvam K., Westphal V., Abraham V., Varki A., Freeze H.H. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. The Journal of Immunology 2001, 166:4678-4688.
37. Štros M. HMGB proteins: interactions with DNA and chromatin. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2010, 1799:101-113.
38. Tang D., Kang R., Cheh C.W., Livesey K.M., Liang X., Schapiro N.E., Benschop R., Sparvero L.J., Amoscato A.A., Tracey K.J., Zeh H.J., Lotze M.T. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010, 29:5299-5310.
39. Tian J., Avalos A.M., Mao S.-Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L.L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M.K., Fitzgerald K.A., Latz E., Kiener P.A., Coyle A.J. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nature Immunology 2007, 8:487-496.
40. Turovskaya O., Foell D., Sinha P., Vogl T., Newlin R., Nayak J., Nguyen M., Olsson A., Nawroth P.P., Bierhaus A., Varki N., Kronenberg M., Freeze H.H., Srikrishna G. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 2008, 29:2035-2043.
41. Udan M.L.D., Ajit D., Crouse N.R., Nichols M.R. Toll-like receptors 2 and 4 mediate Aβ(1-42) activation of the innate immune response in a human monocytic cell line. Journal of Neurochemistry 2008, 104:524-533.
42. van Lent P.L.E.M., Grevers L., Blom A.B., Sloetjes A., Mort J.S., Vogl T., Nacken W., van den Berg W.B., Roth J. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Annals of the Rheumatic Diseases 2008, 67:1750-1758.
43. van Lent P.L.E.M., Grevers L.C., Blom A.B., Arntz O.J., van de Loo F.A.J., van der Kraan P., Abdollahi-Roodsaz S., Srikrishna G., Freeze H., Sloetjes A., Nacken W., Vogl T., Roth J., van den Berg W.B. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis and Rheumatism 2008, 58:3776-3787.
44. van Zoelen M.A.D., Yang H., Florquin S., Meijers J.C.M., Akira S., Arnold B., Nawroth P.P., Bierhaus A., Tracey K.J., Poll T.v.d. Role of Toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 2009, 31:280-284. 10.1097/SHK.0b013e318186262d.
45. Visintin A., Latz E., Monks B.G., Espevik T., Golenbock D.T. Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. Journal of Biological Chemistry 2003, 278:48313-48320.
46. Vogl T. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nature Medicine 2007, 13:1042-1049.
47. Xu D., Young J., Song D., Esko J.D. Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). Journal of Biological Chemistry 2011, 286:41736-41744.
48. Yamamoto Y., Harashima A., Saito H., Tsuneyama K., Munesue S., Motoyoshi S., Han D., Watanabe T., Asano M., Takasawa S., Okamoto H., Shimura S., Karasawa T., Yonekura H., Yamamoto H. Septic shock is associated with receptor for advanced glycation end products ligation of LPS. The Journal of Immunology 2011, 186:3248-3257.
49. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-[beta] peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
50. Yan S.D., Stern D., Kane M.D., Kuo Y.-M., Lampert H.C., Rohe A.E. RAGE-AB interactions in the pathophysiology of Alzheimer's disease. Restorative Neurology and Neuroscience 1998, 12:167-173.
51. Yan S.D., Zhu H., Zhu A., Golabek A., Du H., Roher A., Yu J., Soto C., Schmidt A.M., Stern D., Kindy M. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nature Medicine 2000, 6:643-651.
52. Yang H., Hreggvidsdottir H., Palmblad K., Wang H., Ochani M., Li J., Lu B., Chavan S., Rosas-Ballina M., Al-Abed Y., Akira S., Bierhaus A., Erlandsson-Harris H., Andersson U., Tracey K. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:11942-11947.
53. Yang H., Hreggvidsdottir H.S., Palmblad K., Wang H., Ochani M., Li J., Lu B., Chavan S., Rosas-Ballina M., Al-Abed Y., Akira S., Bierhaus A., Erlandsson-Harris H., Andersson U., Tracey K.J. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proceedings of the National Academy of Sciences 2010, 107:11942-11947.
54. Yang H., Lundback P., Ottosson L., Erlandsson-Harris H., Venereau E., Bianchi M.E., Al-Abed Y., Andersson U., Tracey K.J., Antoine D.J. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Molecular Medicine 2012, 18:250-259.
55. Yu M., Wang H., Ding A., Golenbock D.T., Latz E., Czura C.J., Fenton M.J., Tracey K.J., Yang H. Hmgb1 signals through Toll-like receptor (TLR)4 and TLR2. Shock 2006, 26:174-179. 10.1097/01.shk.0000225404.51320.82.